CCL5 and ovarian cancer: The enhanced invasiveness is mediated through NF-κB activation along with elevated MMP-9 secretion, suggesting that the autocrine activation of CCR1 and CCR3 by CCL5 represents one of the major mechanisms underlying the metastatic property of ovarian cancer cells [26].